NSC-207895, also known as trans-2-phenylcyclopropylamine hydrochloride, is a potent inhibitor of lysine-specific demethylase 1 (LSD1), an enzyme that regulates gene expression by removing methyl groups from histone proteins. This small molecule has been shown to have potent anti-cancer effects, making it a potential candidate for cancer therapy. In this article, we will explore the chemical and molecular properties of NSC-207895, as well as its health benefits, potential effects, and safety.
Chemical Properties:
Chemical name: trans-2-phenylcyclopropylamine hydrochloride Molecular formula: C10H13N.HCl Formula weight: 187.68 g/mol CAS No: 58131-57-0
Top ten keywords from Google:
Synonyms: trans-2-phenylcyclopropylamine HCl 2-Phenylcyclopropylamine hydrochloride NSC207895 1A537704
Health Benefits:
NSC-207895 has been found to have potent anti-cancer effects. It inhibits the LSD1 enzyme, which plays a key role in regulating the expression of genes involved in cancer growth and development. By inhibiting LSD1, NSC-207895 can suppress the growth and proliferation of cancer cells, making it a potential candidate for cancer therapy.
Potential Effects:
NSC-207895 has been shown to have potent anti-tumor effects in various types of cancers, including breast, prostate, and lung cancers. It inhibits the growth and proliferation of cancer cells by blocking the activity of LSD1, which is known to regulate the expression of genes involved in cancer development.
Product Mechanism:
NSC-207895 is a potent inhibitor of LSD1, an enzyme that plays a key role in the regulation of gene expression by removing methyl groups from histone proteins. By inhibiting LSD1, NSC-207895 can suppress the expression of genes involved in cancer development and promote the expression of genes involved in tumor suppression.
Safety:
NSC-207895 has been shown to have low toxicity in animal studies. However, given its potential anti-cancer effects, it is important to use caution when administering this compound. More research is needed to determine the potential long-term effects of NSC-207895 and to establish safe dosages.
Side Effects:
Currently, little is known about the potential side effects of NSC-207895 in humans. Animal studies have shown no significant toxicity, but more research is needed to establish the safety profile of this compound.
Dosing Information:
Currently, there is no established dosing information for NSC-207895 in humans. However, animal studies have shown that doses up to 100 mg/kg are well tolerated and effective in inhibiting tumor growth.
Conclusion:
NSC-207895 is a promising compound that has shown potent anti-cancer effects in preclinical studies. By inhibiting the LSD1 enzyme, this compound can suppress the expression of genes involved in cancer growth and promote the expression of genes involved in tumor suppression. While more research is needed to fully establish the safety and efficacy of NSC-207895 in humans, this compound holds great promise as a potential candidate for cancer therapy.
